Ketamine for Suicidal Ideation: Can It Provide Rapid Relief in Crisis?

If You or Someone You Know Is in Immediate Danger

Please call or text the 988 Suicide & Crisis Lifeline right now by dialing 988. You can also chat at 988lifeline.org. Trained counselors are available 24/7, and you do not have to face this alone.

This article is educational in nature and is not a substitute for emergency crisis intervention. If you are experiencing active suicidal ideation with a plan or intent, please seek immediate help.

---

The Urgent Need for Faster Treatment

Suicidal ideation, the persistent thoughts about ending one's own life, represents one of the most urgent challenges in modern psychiatry. Every year, tens of thousands of Americans die by suicide, and millions more experience suicidal thoughts that cause real suffering for themselves and their loved ones.

What makes this crisis especially painful is the treatment gap. The medications most commonly prescribed for depression and suicidal thinking (SSRIs and SNRIs) can take four to six weeks or longer to reach full therapeutic effect. For someone in acute psychological pain, being told to "wait a few weeks" can feel like an impossible ask.

This timeline gap has led researchers and clinicians to ask a critical question: is there something that works faster?

Over the past two decades, ketamine has emerged as one of the most promising answers. And the research, while still evolving, is striking.

What the Research Shows About Ketamine and Suicidal Thoughts

Multiple clinical studies have demonstrated that ketamine can produce measurable reductions in suicidal ideation within hours of administration. That speed of action is essentially unprecedented in psychiatric medicine.

Key findings include:

• A 2017 individual-participant-data meta-analysis in the American Journal of Psychiatry (Wilkinson et al.) pooled 167 patients across 10 trials and found that a single intravenous dose of ketamine significantly reduced suicidal ideation within 1 day, with effects sustained for up to 1 week. Longer-duration effects in the literature come from repeated-dose protocols (Spravato/esketamine Phase 3 ASPIRE trials, 2020), not single doses.
• A meta-analysis of multiple randomized controlled trials confirmed that ketamine produces rapid anti-suicidal effects that are independent of its antidepressant effects, meaning it appears to target suicidal thinking through its own distinct mechanism.
• Research from Columbia University and the National Institute of Mental Health (NIMH) has consistently shown that ketamine's effects on suicidal ideation begin within the first few hours after treatment, with peak reduction often occurring within the first day.

These findings are significant because they suggest ketamine is not simply reducing suicidal thoughts by improving mood. It appears to act on suicidal ideation through a separate neurobiological pathway, one that researchers are still working to fully understand.

How Ketamine Works Differently Than Traditional Antidepressants

To understand why ketamine acts so much faster, it helps to understand how ketamine works in the brain at a neurological level.

Traditional antidepressants like SSRIs work primarily on the serotonin system. They gradually increase the availability of serotonin in the brain, and over weeks, this shift leads to downstream changes in neural signaling and mood regulation. It is a slow, indirect process.

Ketamine takes a fundamentally different approach:

Glutamate Modulation

Ketamine acts on the glutamate system, the brain's primary excitatory neurotransmitter network. By temporarily blocking NMDA receptors, ketamine triggers a cascade of events that rapidly increases the release of brain-derived neurotrophic factor (BDNF) and activates pathways involved in synaptic plasticity.

Rapid Synaptic Repair

One of the most striking findings in ketamine research is that it appears to promote the rapid formation of new synaptic connections, essentially helping the brain rebuild communication pathways that have been damaged or weakened by chronic depression and psychological distress.

The "Reset" Effect

Many patients describe the experience as a kind of mental reset, a temporary loosening of rigid, hopeless thought patterns that allows space for new perspectives. This is not just subjective; neuroimaging studies show measurable changes in brain connectivity after ketamine treatment.

For a deeper dive into the neuroscience of why this matters for depression specifically, see our explainer on how ketamine works for treatment-resistant depression.

Important Caveats: What Ketamine Is, and What It Is Not

While the research is genuinely promising, responsible medical practice requires that we be very clear about what ketamine can and cannot do in the context of suicidal ideation.

Ketamine is NOT a standalone crisis intervention

Ketamine treatment is not a replacement for calling 988, going to an emergency room, or engaging with a crisis counselor. If you are in immediate danger, you need immediate human support.

Ketamine is NOT a cure for suicidal thinking

It is a tool, a potentially powerful one, that can provide rapid relief and create a window of opportunity for other treatments and therapeutic work to take hold.

Ketamine works best as part of a comprehensive plan

The patients who benefit most from ketamine are those who use it alongside therapy, medication management, lifestyle changes, and ongoing psychiatric care. It is a bridge, not a destination.

Not everyone is a candidate

Ketamine treatment requires careful medical screening. Individuals with certain cardiovascular conditions, active substance use disorders, or specific psychiatric conditions such as psychotic disorders may not be appropriate candidates. See our deep-dives on contraindications and risks and side effects for the full screening picture.

How At-Home Ketamine Therapy Fits Into the Picture

At Discreet Ketamine, we offer medically supervised at-home ketamine therapy for patients in Florida and New Jersey who are dealing with treatment-resistant depression, severe anxiety, and related conditions.

For patients who experience suicidal ideation as a component of their depression (particularly those who have not responded adequately to traditional antidepressants) ketamine therapy can serve as an important part of their treatment plan.

Here is how we approach it responsibly:

1. Thorough medical evaluation. Every patient undergoes a comprehensive psychiatric and medical assessment before treatment begins. We evaluate the severity and nature of symptoms, medication history, and overall safety profile.
2. Ongoing monitoring. Patients are not simply given a prescription and left on their own. Dr. Soffer provides ongoing medical oversight, regular check-ins, and dosage adjustments as needed.
3. Integration with existing care. We work alongside your therapist, psychiatrist, or other providers to ensure ketamine treatment complements your broader care plan.
4. Safety-first protocols. Patients receive clear instructions for their treatment sessions, including having a trusted person present, avoiding driving, and knowing when and how to reach us if concerns arise.

Who Might Benefit From This Approach

Ketamine therapy for suicidal ideation is most appropriate for individuals who:

• Have experienced persistent suicidal thoughts as part of treatment-resistant depression
• Have tried multiple antidepressants without adequate relief
• Are currently stable enough for at-home treatment (not in acute crisis)
• Are engaged with a therapist or counselor and willing to continue that work
• Have been medically cleared through our screening process

It is not appropriate for individuals who are in immediate danger, who have active psychosis, or who are seeking ketamine as their sole form of treatment.

A Note on Hope

If you have been living with suicidal thoughts, you already know how exhausting and isolating that experience can be. You may have tried medication after medication, feeling like nothing will ever work. That hopelessness is not a reflection of reality. It is a symptom of the condition itself.

The emergence of ketamine as a rapid-acting treatment is genuinely meaningful. It does not solve everything, but for many patients, it provides something that has been missing from their treatment: speed. The ability to feel relief in hours rather than weeks can be the difference between giving up and holding on long enough for other treatments to work.

You deserve to explore every option available to you.

Take the Next Step

If you are interested in learning whether ketamine therapy might be appropriate for your situation, we encourage you to check your eligibility. The process is confidential, straightforward, and there is no obligation.

And if you are in crisis right now, please reach out. Call or text 988. Help is available, and it is available right now.

Frequently Asked Questions

How fast does ketamine work for suicidal thoughts?

Faster than any other psychiatric medication we have. Multiple randomized trials (Wilkinson 2017 meta-analysis, Mount Sinai, Columbia, NIMH) show measurable reductions in suicidal ideation within hours of a single dose, with peak effect typically in the first 24 hours and effects sustained for up to a week from one dose. Repeated-dose protocols (the standard 10 or more session induction series) extend the window further. SSRIs by comparison take four to six weeks to reach full effect, which is why ketamine has become so important in the rapid-acting bridge role.

Is ketamine FDA-approved for suicidal ideation?

Spravato (esketamine, the S-enantiomer) is FDA-approved specifically for treatment-resistant depression with active suicidal ideation, based on the ASPIRE trials. Generic racemic ketamine (the form typically used for at-home sublingual treatment) is not FDA-approved for suicidal ideation specifically, but its use for this purpose is extensively studied and is considered an appropriate off-label application. Off-label does not mean experimental; it means the specific FDA approval pathway hasn't been completed.

Can ketamine completely eliminate suicidal thoughts?

For some patients, suicidal ideation drops to near-zero after the first one to two sessions and stays there. For others, the intensity reduces meaningfully but doesn't disappear, and ketamine becomes part of a broader treatment plan. Research consistently shows ketamine's anti-suicidal effect is independent of its antidepressant effect, meaning patients can have reduced suicidal ideation even when overall depression scores haven't fully normalized. The most realistic framing: ketamine creates space for other treatment to take hold, not a guaranteed elimination of all symptoms.

Is at-home ketamine safe for someone with suicidal ideation?

Yes, with appropriate screening and a thoughtful protocol. At-home treatment is appropriate for patients with chronic suicidal ideation as part of treatment-resistant depression who are NOT in acute crisis (no active plan, intent, or recent attempt). Patients in acute crisis need higher-acuity care: 988, an emergency department, or inpatient stabilization. The screening process at intake specifically evaluates whether at-home is appropriate or whether a higher level of care is the right starting point.

Can ketamine cause suicidal thoughts?

A fair question because some psychiatric medications carry "increased suicidal ideation" warnings (especially in adolescents and young adults). The data on ketamine consistently goes the opposite direction: it reduces suicidal ideation. There's no signal in the literature for ketamine increasing suicide risk, and the trials specifically designed to measure anti-suicidal effects (Wilkinson 2017, ASPIRE) all showed reduction. The only caveat is that as ketamine wears off, some patients can experience a partial rebound, which is why repeated-dose induction series produce more durable effects than single doses.

How is ketamine different from Spravato for suicidal ideation?

Spravato (esketamine) is the S-enantiomer of ketamine, given as a nasal spray under direct medical observation in a certified clinic, FDA-approved for treatment-resistant depression with suicidality. At-home ketamine is racemic (R+S enantiomers), typically sublingual, given under physician supervision via telehealth. Both work through the same NMDA-glutamate mechanism. Spravato has the FDA-approval advantage and the acute-crisis safety advantage of in-clinic monitoring; at-home ketamine has accessibility, comfort, and cost advantages for patients who are stable enough for home treatment.

Is ketamine appropriate for someone in active crisis?

Not at-home ketamine. If you or a loved one is experiencing active suicidal ideation with a plan, intent, or recent attempt, the right step is 988 (call or text), an emergency department, or contact with a current psychiatrist for inpatient stabilization. Once acute risk is stabilized, ketamine therapy (Spravato in-clinic or at-home racemic) can be a critical part of preventing future crisis episodes and treating the underlying depression that drives them.

Can ketamine help if I've tried multiple antidepressants without relief?

This is the population where ketamine produces the strongest signal. The standard definition of treatment-resistant depression is failure to respond to two or more adequate antidepressant trials, and most ketamine research has been conducted in exactly this group. Response rates in TRD trials run 50 to 70 percent for ketamine, far higher than the 25 to 30 percent seen with adding a third or fourth conventional antidepressant. If you've cycled through SSRIs, SNRIs, and augmentation strategies without adequate relief, ketamine is one of the most evidence-supported next-step options. See our piece on ketamine after antidepressant failure for the full case.

References

1. Wilkinson ST, Ballard ED, Bloch MH, et al. The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. Am J Psychiatry. 2018;175(2):150-158. PubMed: 28969441 · Free full text

2. Grunebaum MF, Galfalvy HC, Choo TH, et al. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial. Am J Psychiatry. 2018;175(4):327-335. PubMed: 29202655 · Free full text

3. Murrough JW, Soleimani L, DeWilde KE, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med. 2015;45(16):3571-3580. PubMed: 26266877

4. Fu DJ, Ionescu DF, Li X, et al. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I). J Clin Psychiatry. 2020;81(3):19m13191. PubMed: 32412700

5. Ionescu DF, Fu DJ, Qiu X, et al. Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II). Int J Neuropsychopharmacol. 2021;24(1):22-31. PubMed: 32861217

6. Zarate CA Jr, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856-864. PubMed: 16894061

---

Disclaimer: This blog post is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Ketamine therapy is a prescription medical treatment that must be administered under the supervision of a licensed healthcare provider. Individual results vary, and ketamine is not appropriate for all patients. If you are experiencing suicidal thoughts, please contact the 988 Suicide & Crisis Lifeline by calling or texting 988, or go to your nearest emergency room. Always consult with a qualified healthcare provider before starting any new treatment.